Results 11 to 20 of about 2,151 (196)

Prognostic Factors and Life Expectancy in Canine Leishmaniosis [PDF]

open access: yesVeterinary Sciences, 2020
Canine leishmaniosis (CanL) is a chronic and potentially fatal disease. The prognosis of CanL depends on the severity of the clinical signs and clinicopathological abnormalities presented by the dog at the time of diagnosis.
Maria A Pereira   +2 more
exaly   +8 more sources

Retrospective study of canine leishmaniosis in Israel [PDF]

open access: yesParasites & Vectors
Background Canine and human leishmaniasis are prevalent around the Mediterranean Basin, where dogs are considered to be the main peridomestic reservoir for human disease. Canine leishmaniosis was initially diagnosed in central Israel in 1994. Since then,
Gad Baneth   +5 more
doaj   +4 more sources

LeishVet guidelines for the practical management of canine leishmaniosis [PDF]

open access: yesParasites & Vectors, 2011
The LeishVet group has formed recommendations designed primarily to help the veterinary clinician in the management of canine leishmaniosis. The complexity of this zoonotic infection and the wide range of its clinical manifestations, from inapparent ...
Bourdeau Patrick   +8 more
doaj   +8 more sources

Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis [PDF]

open access: yesPathogens, 2023
Miltefosine-Allopurinol (MIL-AL) combination is reported to be one of the most effective treatments for canine leishmaniosis, thanks to its oral administration and MIL-documented low impact on renal function. However, MIL-AL is considered a second-choice
Manuela Gizzarelli   +2 more
exaly   +4 more sources

Is pancreatitis associated with meglumine antimoniate treatment for canine leishmaniosis? A multicentric prospective study [PDF]

open access: yesParasites & Vectors
Background Meglumine antimoniate is used to treat canine leishmaniosis. In humans, it has been associated with pancreatitis. Although a few case reports have described acute pancreatitis secondary to antimonial treatment in dogs, some studies have ...
Clàudia Viñeta   +6 more
doaj   +3 more sources

Canine leishmaniosis in Tunisia: Growing prevalence, larger zones of infection. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2021
BackgroundDiscovered by Nicolle and Comte in 1908 in Tunisia, Leishmania infantum is an intracellular protozoan responsible for zoonotic canine leishmaniosis (CanL) and zoonotic human visceral leishmaniasis (HVL).
Ali Bouattour   +6 more
doaj   +5 more sources

Canine Leishmaniosis [PDF]

open access: yesRevista MVZ Córdoba, 2015
Se realiza un análisis crítico con el fin de orientar a los médicos veterinarios en el tema de Leishmaniosis canina. Se realizó una revisión de literatura a partir del año 2005 de manera sistemática considerando artículos científicos donde se tuvieran en cuenta experiencias y reportes de la patogenia, diagnóstico, presentación clínica de la enfermedad,
Acero, Víctor   +4 more
core   +9 more sources

Data Independent Acquisition Reveals In-Depth Serum Proteome Changes in Canine Leishmaniosis [PDF]

open access: yesMetabolites, 2023
Comprehensive profiling of serum proteome provides valuable clues of health status and pathophysiological processes, making it the main strategy in biomarker discovery.
Franjo Martinković   +5 more
doaj   +2 more sources

Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy [PDF]

open access: yesParasites & Vectors, 2023
Background Leishmania infantum is an intracellular protozoan parasite which is endemic in countries of the Mediterranean Basin. Leishmaniosis is increasingly diagnosed in non-endemic areas due to the relocation of dogs from endemic areas and the travel ...
Marja Klazina de Jong   +3 more
doaj   +2 more sources

Angiopoietin-1, Angiopoietin-2 and Vascular Endothelial Growth Factor Levels in Canine Leishmaniosis. [PDF]

open access: yesVet Med Sci
Ang‐1, Ang‐2 and VEGF levels significantly varied in different stages of canine leishmaniosis. ABSTRACT Background Canine leishmaniosis (CanL) is a zoonotic vector–borne disease and is primarily associated with systemic inflammation, endothelial dysfunction and immune dysregulation.
Gultekin G   +10 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy